Literature DB >> 11396857

Detailed organization of nitric oxide synthase, vasopressin and oxytocin immunoreactive cell bodies in the supraoptic nucleus of the female rat.

A Nylén1, G Skagerberg, P Alm, B Larsson, B I Holmqvist, K E Andersson.   

Abstract

The anatomical distribution and quantitative relations of cell bodies containing neuronal nitric oxide synthase (nNOS), 8-arginine vasopressin (AVP) and oxytocin (OT) were examined throughout the supraoptic nucleus (SON) of the female rat by means of immunocytochemical and NADPH-diaphorase (NADPH-d) histochemical techniques using a triple labelling methodology. Seven chemically defined populations of neurons containing all combinations of either nNOS, AVP or OT were identified. nNOS-containing (NADPH-d positive) neurons, amounting to about 40% of all neurons counted, were most frequent in central and dorsal regions, and were evenly distributed along the rostro-caudal axis. Two small nNOS-positive neuronal populations were preferentially located dorso-centrally in the nucleus: nNOS-positive neurons containing both AVP- and OT-immunoreactivity, and neurons only containing nNOS. Slightly less than half of all nNOS-positive neurons contained AVP, and a similar share of nNOS-positive neurons contained OT. The occurrence of nNOS-positive/AVP-containing neurons was highest in the caudal half, whereas that of nNOS-positive/OT-neurons was highest in the rostral half of SON. The data demonstrate new findings concerning the anatomical organization and co-localization patterns of nNOS-, AVP- and OT-containing neuronal populations in SON. We conclude that the absolute and relative occurrence of the identified neuronal populations vary markedly in different parts of SON. This is important to take into consideration when performing, and evaluating experimental investigations concerned with neurochemical changes in SON.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11396857     DOI: 10.1007/s004290100164

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  7 in total

1.  Neuronal-derived nitric oxide and somatodendritically released vasopressin regulate neurovascular coupling in the rat hypothalamic supraoptic nucleus.

Authors:  Wenting Du; Javier E Stern; Jessica A Filosa
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

2.  Enhanced expression of heme oxygenase-1 and carbon monoxide excitatory effects in oxytocin and vasopressin neurones during water deprivation.

Authors:  W L Reis; V C Biancardi; S Son; J Antunes-Rodrigues; J E Stern
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

3.  Perinatal exposure to octabromodiphenyl ether mixture, DE-79, alters the vasopressinergic system in adult rats.

Authors:  Mhar Y Alvarez-Gonzalez; Eduardo Sánchez-Islas; Samuel Mucio-Ramirez; Patricia de Gortari; María I Amaya; Prasada Rao S Kodavanti; Martha León-Olea
Journal:  Toxicol Appl Pharmacol       Date:  2020-02-04       Impact factor: 4.219

4.  Contribution of central nervous system endothelial nitric oxide synthase to neurohumoral activation in heart failure rats.

Authors:  Vinicia C Biancardi; Sook J Son; Patrick M Sonner; Hong Zheng; Kaushik P Patel; Javier E Stern
Journal:  Hypertension       Date:  2011-08-08       Impact factor: 10.190

5.  Cellular sources, targets and actions of constitutive nitric oxide in the magnocellular neurosecretory system of the rat.

Authors:  Javier E Stern; Wenfeng Zhang
Journal:  J Physiol       Date:  2004-11-18       Impact factor: 5.182

6.  Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways.

Authors:  Shi Di; Marc M Maxson; Alier Franco; Jeffrey G Tasker
Journal:  J Neurosci       Date:  2009-01-14       Impact factor: 6.167

7.  The projection and synaptic organisation of NTS afferent connections with presympathetic neurons, GABA and nNOS neurons in the paraventricular nucleus of the hypothalamus.

Authors:  V S Affleck; J H Coote; S Pyner
Journal:  Neuroscience       Date:  2012-06-12       Impact factor: 3.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.